• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幼年Mustard手术的长期预后:术后长达五十年的纵向随访

Long-Term Outcome After Mustard Repair at Young Age: Longitudinal Follow-Up Into the Fifth Decade After Surgery.

作者信息

Ünlütürk Sahra, Kauling Robert M, Cuypers Judith A A E, van den Bosch Annemien E, Hirsch Alexander, Driessen Mieke M P, Pelosi Chiara, Bowen Daniel J, Bogers Ad J J C, Helbing Willem A, Kardys Isabella, Roos-Hesselink Jolien W

机构信息

Department of Cardiology, Cardiovascular Institute, Thorax Center, Erasmus Medical Center, Rotterdam, the Netherlands.

Department of Cardiology, Cardiovascular Institute, Thorax Center, Erasmus Medical Center, Rotterdam, the Netherlands; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart), Amsterdam, The Netherlands.

出版信息

JACC Adv. 2025 Jul 11;4(8):101984. doi: 10.1016/j.jacadv.2025.101984.

DOI:10.1016/j.jacadv.2025.101984
PMID:40651316
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12275045/
Abstract

BACKGROUND

Concerns remain regarding the high incidence of morbidity in transposition of the great arteries (TGA) patients who underwent Mustard repair.

OBJECTIVES

The purpose of this study was to evaluate the long-term outcome and quality of life of patients with TGA up to 48 years.

METHODS

Single-center, longitudinal cohort study evaluating consecutive patients with TGA who underwent Mustard repair between 1973 and 1980 at young age with extensive cardiac and subjective quality of life evaluation every decade.

RESULTS

Of the original cohort of 91 patients, 31 died and 2 underwent heart transplantation. Cumulative survival at 48 years was 61% (51% to 73%), with a shift in cause of death from sudden death to heart failure (HF) after 35 years of follow-up. Of the 44 eligible survivors, 34 (77%) were evaluated (71% male, median age 46 years) with a median follow-up of 46 (range: 40-48) years. Event-free survival was 14%, with cardiac reintervention (39%), symptomatic arrhythmia (39%), and HF (37%) being the most common events. Systemic right ventricular function (sRVF) declined over time, with 73% having an ejection fraction below 40%, and 95% having a reduced VOmax. Prolonged QRS duration was found to be a predictor for HF, early postoperative arrhythmias for late symptomatic arrhythmias, and a reduced sRVF for mortality. Self-perceived quality of life was good and remained stable over time.

CONCLUSIONS

Mortality and morbidity after Mustard repair are substantial, with an event-free survival of only 14% at 48 years. The clinical condition deteriorated over time, necessitating timely consideration of advanced treatment options.

摘要

背景

对于接受Mustard修复术的大动脉转位(TGA)患者,其高发病率问题仍然令人担忧。

目的

本研究旨在评估年龄达48岁的TGA患者的长期预后和生活质量。

方法

单中心纵向队列研究,评估1973年至1980年间年轻时接受Mustard修复术的连续TGA患者,每十年进行广泛的心脏及主观生活质量评估。

结果

在最初的91例患者队列中,31例死亡,2例接受心脏移植。48岁时的累积生存率为61%(51%至73%),随访35年后死亡原因从猝死转变为心力衰竭(HF)。在44例符合条件的幸存者中,34例(77%)接受了评估(71%为男性,中位年龄46岁),中位随访时间为46年(范围:40 - 48年)。无事件生存率为14%,心脏再次干预(39%)、症状性心律失常(39%)和HF(37%)是最常见的事件。体循环右心室功能(sRVF)随时间下降,73%的患者射血分数低于40%,95%的患者最大摄氧量降低。发现QRS时限延长是HF的预测指标,术后早期心律失常是晚期症状性心律失常的预测指标,sRVF降低是死亡率的预测指标。自我感知的生活质量良好且随时间保持稳定。

结论

Mustard修复术后的死亡率和发病率很高,48岁时无事件生存率仅为14%。临床状况随时间恶化,需要及时考虑先进的治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b457/12275045/3da930b700a3/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b457/12275045/4294978d9547/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b457/12275045/4294978d9547/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b457/12275045/0494dcdaff51/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b457/12275045/0f2e660c7ba9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b457/12275045/318d8b2fa825/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b457/12275045/3da930b700a3/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b457/12275045/4294978d9547/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b457/12275045/4294978d9547/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b457/12275045/0494dcdaff51/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b457/12275045/0f2e660c7ba9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b457/12275045/318d8b2fa825/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b457/12275045/3da930b700a3/gr4.jpg

相似文献

1
Long-Term Outcome After Mustard Repair at Young Age: Longitudinal Follow-Up Into the Fifth Decade After Surgery.幼年Mustard手术的长期预后:术后长达五十年的纵向随访
JACC Adv. 2025 Jul 11;4(8):101984. doi: 10.1016/j.jacadv.2025.101984.
2
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Long-Term Outcome Following Prenatal Diagnosis of Transposition of the Great Arteries.大动脉转位产前诊断后的长期结局
Pediatr Cardiol. 2025 Jul 15. doi: 10.1007/s00246-025-03939-w.
5
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
8
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
10
Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.用于治疗心律失常的植入式心脏复律除颤器和用于治疗心力衰竭的心脏再同步治疗:系统评价与经济学评估
Health Technol Assess. 2014 Aug;18(56):1-560. doi: 10.3310/hta18560.

本文引用的文献

1
Ventricular assist device implantation in adults with a systemic right ventricle - A single center experience and review of the literature.成人系统性右心室患者的心室辅助装置植入术——单中心经验及文献综述
Int J Cardiol Congenit Heart Dis. 2022 Mar 29;8:100365. doi: 10.1016/j.ijcchd.2022.100365. eCollection 2022 Jun.
2
Impaired Exercise Capacity and Mortality Risk in Adults With Congenital Heart Disease.先天性心脏病成人的运动能力受损与死亡风险
JACC Adv. 2023 Jul 28;2(5):100422. doi: 10.1016/j.jacadv.2023.100422. eCollection 2023 Jul.
3
Life expectancy and end-of-life communication in adult patients with congenital heart disease, 40-53 years after surgery.
先天性心脏病成年患者术后40至53年的预期寿命及临终沟通
Eur Heart J Open. 2023 Jul 13;3(4):oead067. doi: 10.1093/ehjopen/oead067. eCollection 2023 Jul.
4
Tolerability and beneficial effects of sacubitril/valsartan on systemic right ventricular failure.沙库巴曲缬沙坦对体循环右心室衰竭的耐受性及有益作用。
Heart. 2023 Sep 28;109(20):1525-1532. doi: 10.1136/heartjnl-2022-322332.
5
Safety and Efficacy of Sacubitril/Valsartan in Patients With a Failing Systemic Right Ventricle: A Prospective Single-Center Study.沙库巴曲缬沙坦治疗右心室功能衰竭患者的安全性和有效性:一项前瞻性单中心研究
Circ Heart Fail. 2023 Feb;16(2):e009848. doi: 10.1161/CIRCHEARTFAILURE.122.009848. Epub 2022 Dec 2.
6
Clinical factors affecting survival in patients with D-transposition of the great arteries after atrial switch repair: A meta-analysis.心房调转修复术后大动脉D型转位患者生存的临床影响因素:一项荟萃分析。
Kardiol Pol. 2023;81(1):38-47. doi: 10.33963/KP.a2022.0209. Epub 2022 Sep 9.
7
Predictors of mortality after atrial correction of transposition of the great arteries.大动脉转位矫正术后的死亡率预测因素。
Heart. 2022 Nov 10;108(23):1881-1886. doi: 10.1136/heartjnl-2021-320035.
8
A new score for life-threatening ventricular arrhythmias and sudden cardiac death in adults with transposition of the great arteries and a systemic right ventricle.一种新的评分系统,用于预测大动脉转位合并体静脉异位引流患者发生致命性室性心律失常和心源性猝死的风险。
Eur Heart J. 2022 Jul 21;43(28):2685-2694. doi: 10.1093/eurheartj/ehac288.
9
Patient education, engagement, and empowerment: the time is now.患者教育、参与和赋权:时机已至。
Eur Heart J. 2022 May 21;43(20):1897-1898. doi: 10.1093/eurheartj/ehab817.
10
Effect of medical treatment on heart failure incidence in patients with a systemic right ventricle.医学治疗对系统性右心室心力衰竭患者发病率的影响。
Heart. 2021 Sep;107(17):1384-1389. doi: 10.1136/heartjnl-2020-318787. Epub 2021 May 6.